RDF/XML JSON-LD N3/Turtle RDF/JSON
Author profile at the institutional portal

Quintela Fandiño, Miguel Angel miguel.quintela@uam.es

Medicina / Universidad Autónoma de Madrid

Publications

Addition of durvalumab (Dur) upon progression to bevacizumab (Bev) maintenance in advanced HER2-negative (HERNEG) breast cancer (BC): Safety, efficacy and biomarkers

  • Quintela-Fandino M
  • Manso Sànchez LM
  • Holgado Martín E
  • Moreno MC
  • Morales Murillo S
  • Bermejo De Las Heras B
  • Malon Gimenez D
  • Colomer Bosch R
  • Gonzalez Cortijo L
  • Hornedo J
  • Mouron S
  • Muñoz M
  • Escudero S
  • Blanco R
  • Mañes S
... View more Collapse

Annals Of Oncology - 1/11/2018

10.1093/annonc/mdy430.003 View at source

  • ISSN 09237534

Analysis of paired primary-metastatic hormone-receptor positive breast tumors (HRPBC) uncovers potential novel drivers of hormonal resistance

  • Manso L., Mourón S., Tress M., Gómez-López G., Morente M., Ciruelos E., Rubio-Camarillo M., Rodriguez-Peralto J.L., Pujana M.A., Pisano D.G., Quintela-Fandino M.

Plos One - 1/5/2016

10.1371/journal.pone.0155840

  • ISSN 19326203
  • iMarina

Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality

  • Lord, Simon
  • Funes, Juan M.
  • Harris, Adrian L.
  • Quintela-Fandino, Miguel;

Current Drug Targets (p. 1714-1727) - 1/1/2016

10.2174/1389450117666160307143718 View at source

  • ISSN 13894501

Antiangiogenics and hypoxic response: Role of fatty acid synthase inhibitors

  • Bueno M
  • Sanchez J
  • Colomer R
  • Quintela-Fandino M

Current Drug Targets (p. 1735-1746) - 1/1/2016

10.2174/1389450117666160502151857 View at source

  • ISSN 13894501

Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support

  • Quintela-Fandino, Miguel
  • Lopez, Joaquin Martinez
  • Hitt, Ricardo
  • Gamarra, Soledad
  • Jimeno, Antonio
  • Ayala, Rosa
  • Hornedo, Javier
  • Guzman, Cecilia
  • Gilsanz, Florinda
  • Cortes-Funes, Hernan
... View more Collapse

Journal Of Clinical Oncology (p. 3611-3618) - 1/8/2006

10.1200/jco.2005.04.0576 View at source

  • ISSN 0732183X

CX3CL1 promotes breast cancer via transactivation of the EGF pathway

  • Tardáguila M, Mira E, García-Cabezas MA, Feijoo AM, Quintela-Fandino M, Azcoitia I, Lira SA, Mañes S

Cancer Research (p. 4461-4473) - 15/7/2013

10.1158/0008-5472.can-12-3828

  • ISSN 00085472
  • iMarina

Coexistence of two rare sarcomas: Primary leiomyosarcoma of bone and epithelioid hemangioendothelioma of the liver

  • Gonzalez-Billalabeitia E
  • Quintela-Fandino M
  • Alemany I
  • López-Alonso G
  • Ruiz-Ollero A
  • Martinez-Tello F
  • Hitt R
... View more Collapse

Sarcoma - 23/5/2008

10.1155/2008/416085 View at source

  • ISSN 13691643

Colorectal hepatic metastases: Intraarterial chemotherapy

  • Grávalos Castro C
  • Murillo González T
  • Quintela-Fandino M

Revisiones En Cancer (p. 226-238) - 3/12/2004

  • ISSN 02138573
  • iMarina

Coordinated signals from PARP-1 and PARP-2 are required to establish a proper T cell immune response to breast tumors in mice

  • Moreno-Lama L
  • Galindo-Campos MA
  • Martínez C
  • Comerma L
  • Vazquez I
  • Vernet-Tomas M
  • Ampurdanés C
  • Lutfi N
  • Martin-Caballero J
  • Dantzer F
  • Quintela-Fandino M
  • Ali SO
  • Jimeno J
  • Yélamos J
... View more Collapse

Oncogene (p. 2835-2843) - 26/3/2020

10.1038/s41388-020-1175-x View at source

  • ISSN 09509232

Critically short telomeres and toxicity of chemotherapy in early breast cancer

  • Quintela-Fandino M
  • Soberon N
  • Lluch A
  • Manso L
  • Calvo I
  • Cortes J
  • Moreno-Antón F
  • Gil-Gil M
  • Martinez-Jánez N
  • Gonzalez-Martin A
  • Adrover E
  • de Andres R
  • Viñas G
  • Llombart-Cussac A
  • Alba E
  • Mouron S
  • Guerra J
  • Bermejo B
  • Zamora E
  • García-Saenz JA
  • Simon SP
  • Carrasco E
  • Escudero MJ
  • Campo R
  • Colomer R
  • Blasco MA
... View more Collapse

Oncotarget (p. 21472-21482) - 1/1/2017

10.18632/oncotarget.15592

  • ISSN 19492553
  • iMarina

This researcher has no books.

This researcher has no book chapters.

Phase I clinical trial of neoadjuvant BIBF1120 plus weekly paclitaxel (P) in early HER-2 negative breast cancer. CNIO-BR-01-2010 GEICAM 2010-10 study

  • Quintela-Fandino, M.
  • Urruticoechea, A.
  • Guerra, J.
  • Gil, M.
  • Gonzalez-Martin, A.
  • Marquez, R.
  • Hernandez-Agudo, E.
  • Rodriguez-Martin, C.
  • Gil, M.
  • Bratos, R.
  • Escudero, M. J.
  • Colomer, R.;
... View more Collapse

Cancer Research - 15/12/2013

10.1158/0008-5472.sabcs13-pd5-8 View at source

  • ISSN 00085472

This researcher has no working papers.

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3K?/?, in Patients with Advanced Solid Tumors

  • Choudhury AD, Higano CS, de Bono JS, Cook N, Rathkopf DE, Wisinski KB, Martin-Liberal J, Linch M, Heath EI, Baird RD, García-Carbacho J, Quintela-Fandino M, Barry ST, de Bruin EC, Colebrook S, Hawkins G, Klinowska T, Maroj B, Moorthy G, Mortimer PG, Moschetta M, Nikolaou M, Sainsbury L, Shapiro GI, Siu LL, Hansen AR

Clinical Cancer Research (p. 2257-2269) - 1/1/2022

10.1158/1078-0432.ccr-21-3087 View at source

  • ISSN 15573265

This researcher has no research projects.

Triple negative breast cancer kinome-taxonomy, prognostic and therapeutics: role of polynucleotide kinase-phosphatase

  • QUINTELA FANDIÑO, MIGUEL ANGEL (Director) Doctorando: Fernández Gaitero, Sara

4/3/2021

  • iMarina

This researcher has no patents or software licenses.

Last data update: 3/18/24 2:43 PM